Name: MarketsandMarkets Virtual conference on Single-Cell Analysis (Time Zone -Eastern Standard Time (EST))
Start: 2020-11-16
End: 2020-11-17

EVENT OVERVIEW

Single-cell sequencing (SCS) is new effective tool for investigating the evolution and variety of most cancers and role of circulating tumor cells in cancer progression. These methods have started to unravel key questions in cancer biology which have been hard to deal with for bulk tumor measurements. Over the span of 5 years, there has been exceptional development in technology and applications of Single-cell analysis.

Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and, ultimately guide diagnosis and treatment option.

Our MarketsandMarkets Virtual conference on Single-Cell analysis scheduled to be held on 16th and 17th November aims to bring together the Researchers, Scientists from top universities and Pharmaceutical companies from all around the globe to address the recent developments and challenges in analyzing single cell and also provides the platform to share the knowledge with academic peers and present their research papers and reports.

The growth of Single-Cell analysis in recent years
Address the challenges faced to isolate Single-Cell
Single-Cell and microfluidics
Advancement in technology to detect metastatic cancer
Progression of single-cell sequencing in cancer genomics
Future opportunities with Single-Cell analysis

Learn about the Single- Cell Biology and its applications
Meet global leaders and researchers from the industry and Academics
100+ Professional attending from all around the globe
Access to online presentations on-demand post-summit
Case studies presented from leading technology collaborations
Interactive panel discussions
Futuristic Agenda
Program address the recent challenges in the field of research

CONFERENCE AGENDA

Online Registration	08:30 - 08:55
Welcome note from MarketsandMarkets	08:55 - 09:00
Opening remarks from the Chairman Srikanthi Ramachandrula, Associate Director - NGS Applications, Strand Life	09:00 - 09:10
THE GROWTH OF SINGLE- CELL ANALYSIS IN RECENT YEARS
Single-cell isolation: The Swiss knife you should have before you star Cátia Moutinho, Group Leader Single Cell Technology Development, GWCCG, Australia	09:10 - 09:35
Using Single Cell and Spatial Technologies to Fuel the Century of Biology Anushka Brownley, Senior Product Manager, Informatics, 10X Genomics	09:35 - 10:05
Singe Cell Analysis Power and Pitfalls Anka G. Ehrhardt, Director, Cell-Based Sciences, AR&D, Merck	10:05 - 10:30
Modern solutions for modern techniques: single cell RNA-seq data analysis and visualization with Basepair Dr. Amit Sinha, Founder and CEO, Basepair	10:30 - 11:00
Unique Microfluidic Technology for Fast and Gentle Single Cell Isolation Rachel Agoglia, Application Scientist, Namocell	11:00 - 11:30
One-To-One Networking Break	11:30 - 11:45
Gallbladder Cancer: Identification of novel targets and drug development Mahendra K. Singh, Ph.D., Research Assistant Professor – Department of Surgery, University of Miami Miller School of Medicine, Member - Sylvester Comprehensive Cancer Center	11:45 - 12:10
Simplifying Single Cell Analysis with ROSALIND Jean Lozach, Chief Scientific Officer, OnRamp Bioinformatics	12:10 - 12:40
Single cell sequencing and cell therapies Leo Perfect, Stem Cell Biologist and Bioinformatician, MHRA	12:40 - 01:05
Single-cell DNA and Protein Multi-omics Sequencing Kelly Kaihara, Marketing Development Manager, Mission Bio	13:05 - 13:35
Single-cell transcriptomes of patient-derived organoids capture intratumoral tumor heterogeneity in glioblastoma Richa Singhania, Director, Brain Organoid Core, Weill Cornell Medicine	13:35 - 14:00
Closing remarks from Chairman	14:00 - 14:00
One-to-One networking break	14:00 - 14:30
End of Day 1	14:30 - 14:30

Online Registration	08:30 - 08:55
Welcome note from MarketsandMarkets	08:55 - 09:00
Opening remarks from the Chairman Dr Catherine Alix-Panabieres PhD, Director of the Laboratory Rare Circulating Human Cells (LCCRH), l’Université et CHU de Montpellier, France, Europe	09:00 - 09:10
TECHNOLOGICAL IMPROVEMENTS IN ANALYZING SINGLE- CELL
Viable Single Cell Analysis & Circulating Tumor Cells (CTCs) as Liquid Biopsy in Cancer Patients Dr Catherine Alix-Panabieres PhD, Director of the Laboratory Rare Circulating Human Cells (LCCRH), l’Université et CHU de Montpellier, France, Europe	09:10 - 09:35
Miniaturization and Automation of Single-cell Sequencing Workflows for Clinical Samples Elly Sinkala, Lead Application Scientist, Cytena	09:35 - 10:05
Cutting Edge Genomics Technologies to Spatially Resolve Tissue Microenvironments Neeraj Salathia, Principal Scientist, Bristol Myers Squibb, USA	10:05 - 10:30
Microfluidics for single cell analysis Meghan Hemond, Senior Product Engineer, Edge Embossing Inc	10:30 - 11:00
One-to-One Networking Break	11:00 - 11:15
CLINICAL APPLICATIONS OF SINGLE-CELL ANALYSIS
Streamline Variant Analysis with GenomOncology’s Annotation API Ian Maurer, Chief Technology Officer, Genomoncology	11:15 - 11:45
Single Cell at Scale with Broad ‘s Genomics Platform Tera Bowers, Associate Director, Portfolio Management, Broad Institute of MIT and Harvard	11:45 - 12:10
Streamlining scRNA-Seq Data Management and Analysis Srikanthi Ramachandrula, Associate Director - NGS Applications, Strand Life	12:10 - 12:40
In-depth single-cell proteomics enabled by nanoliter sample processing and ultrasensitive mass spectrometry Ryan Kelly, Associate Professor, Brigham Young University	12:40 - 01:05
Singulator 100 System for Automated Dissociation of Solid Tissue for Single Cell ‘Omics John Bashkin, Chief Strategy Officer, S2 Genomics	13:05 - 13:35
Single cell analysis tools to explore viral infection Nagarjun Kasaraneni, Ph.D., Scientist, Sana Biotechnology	13:35 - 14:00
Closing remarks from Chairman	14:00 - 14:05
One-to-One networking break	14:05 - 14:35
End of Conference	14:35 - 14:35

Leo Perfect

Stem Cell Biologist and Bioinformatician, MHRA

Dr. Catia Moutinho

Group Leader Single Cell Technology Development, GWCCG, Australia

Jean Lozach

Chief Scientific Officer, OnRamp Bioinformatics

John Bashkin

Chief Strategy Officer, S2 Genomics

Kelly Kaihara

Marketing Development Manager, Mission Bio

Meghan Hemond

Senior Product Engineer, Edge Embossing Inc

Srikanthi Ramachandrula

Associate Director - NGS Applications, Strand Life

Elly Sinkala

Lead Application Scientist, Cytena

Ian Maurer

Chief Technology Officer, Genomoncology

Rachel Agoglia

Application Scientist, Namocell

Anka G. Ehrhardt

Director, Cell-Based Sciences, AR&D, Merck

Tera Bowers

Associate Director, Portfolio Management, Broad Institute of MIT and Harvard

Richa Singhania

Director, Brain Organoid Core, Weill Cornell Medicine

Ryan Kelly

Associate Professor, Brigham Young University

Dr. Amit Sinha

Founder and CEO, Basepair

Anushka Brownley

Senior Product Manager, Informatics, 10X Genomics

Dr Catherine Alix-Panabieres PhD

Director of the Laboratory Rare Circulating Human Cells (LCCRH), l’Université et CHU de Montpellier, France, Europe

Neeraj Salathia

Principal Scientist, Bristol Myers Squibb, USA

Nagarjun Kasaraneni, Ph.D.

Scientist, Sana Biotechnology

Mahendra K. Singh, Ph.D.

Research Assistant Professor – Department of Surgery, University of Miami Miller School of Medicine, Member - Sylvester Comprehensive Cancer Center